Altshuler Shaham Ltd grew its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 42,200.0% during the 4th quarter, Holdings Channel reports. The fund owned 2,115 shares of the semiconductor company’s stock after acquiring an additional 2,110 shares during the period. Altshuler Shaham Ltd’s holdings in Synopsys were worth $993,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in SNPS. Freestone Grove Partners LP purchased a new position in Synopsys during the fourth quarter worth about $1,565,000. Guggenheim Capital LLC grew its stake in shares of Synopsys by 3.8% in the fourth quarter. Guggenheim Capital LLC now owns 128,515 shares of the semiconductor company’s stock valued at $60,366,000 after buying an additional 4,657 shares in the last quarter. Caisse de depot et placement du Quebec grew its stake in shares of Synopsys by 675.2% in the fourth quarter. Caisse de depot et placement du Quebec now owns 171,317 shares of the semiconductor company’s stock valued at $80,471,000 after buying an additional 149,217 shares in the last quarter. Synergy Financial Group LTD grew its stake in shares of Synopsys by 6.2% in the fourth quarter. Synergy Financial Group LTD now owns 599 shares of the semiconductor company’s stock valued at $281,000 after buying an additional 35 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in shares of Synopsys in the fourth quarter valued at about $1,156,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.
Synopsys Stock Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s quarterly revenue was up 41.9% on a year-over-year basis. During the same period in the previous year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Analyst Ratings Changes
SNPS has been the subject of a number of recent analyst reports. HSBC lowered Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research note on Friday, February 20th. Bank of America raised their price target on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Stifel Nicolaus raised their price target on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. BNP Paribas Exane lifted their target price on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Finally, Robert W. Baird set a $558.00 target price on Synopsys in a research note on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $563.81.
Check Out Our Latest Stock Analysis on SNPS
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys announced the first wave of its Multiphysics Fusion solutions, which integrate multiphysics analysis into design workflows and could improve chip design speed, accuracy, and customer adoption. Synopsys Announces Availability of the First Wave of Multiphysics Fusion Solutions
- Positive Sentiment: Synopsys also expanded its ecosystem through a partnership with Murata to provide simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, a move that supports its engineering software platform. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
- Neutral Sentiment: A 247WallSt. commentary said SNPS has been stuck in a weak trading pattern this year, but still projected a year-end price target above current levels, reinforcing a mixed but not bearish long-term view. Synopsys Stock Will End The Year at This Price
- Neutral Sentiment: A DCF-based valuation piece said Synopsys looks fairly valued around $394, suggesting the stock may not be deeply undervalued despite recent weakness. SNPS Fairly Valued by DCF at 394
- Negative Sentiment: CEO Sassine Ghazi sold 14,603 shares and CFO Shelagh Glaser sold 3,394 shares under pre-arranged 10b5-1 plans, which may be routine but can still weigh on investor sentiment. Top Synopsys Executive Makes Major Move With Insider Stock Sale
- Negative Sentiment: Brokerage coverage continues to show a cautious stance overall, with consensus at “Hold,” which may limit enthusiasm despite solid earnings and revenue growth. Synopsys, Inc. Given Consensus Rating of Hold by Brokerages
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
